title: Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients.
abstract: OBJECTIVE
  The usefulness and prognostic impact of a pretherapeutic clinical staging is still a matter of discussion. However, a pretherapeutic estimation of the prognosis would be essential to adjust the patient's therapy. Our aim was to compare clinical and histopathological staging and to analyze the predictive value of routine clinical staging and its significance for the individualization of treatment.
  
  
  METHODS
  We analyzed the data of 368 patients treated with gastric cancer in the University of Heidelberg, Department of Surgery, from January 2001 to June 2009. Pretherapeutic parameters including sex, age, cTNM, grading, Laurén classification, tumor localization, as well as posttherapeutic parameters were analyzed, and their impact for survival was evaluated. Follow-up data was obtained for all patients (2.17% lost to follow-up).
  
  
  RESULTS
  The overall accuracy was 64.1% for pT category, 54.5% for pN category, and 80.3% for M category for the primary resected patients. For the patients treated neoadjuvantly, the overall accuracy was 21.8% for the pT category, 58.0% for the pN category, and 80.0% for the M category. The prognosis was associated to the age (p = 0.017), tumor localization (p < 0.001), grading (p = 0.041), cT category (p < 0.001), cN category (p < 0.001), and cM category (p = 0.001). The multivariate analysis, including pre- and postoperative factors, revealed tumor localization (p = 0.002), cN category (p = 0.019), and metastatic lymph node rate (p < 0.001) as independent prognostic factors.
  
  
  CONCLUSIONS
  The accordance between clinical and histopathological staging is limited, but nevertheless pretherapeutic parameters have a high prognostic impact and could be used for individualized therapy planning. The relevant pretherapeutic prognostic factors can all be determined by routine clinical staging including CT and endoscopy. Consequently pretherapeutic prognostic evaluation and therapy planning seem to be feasible with routine staging methods.
authors: Surgical Department, University Hospital Heidelberg, INF 110, Heidelberg, 69120, Germany.
authors: Susanne
authors: S
authors: Blank
authors: Hendrik
authors: H
authors: Bläker
authors: Anja
authors: A
authors: Schaible
authors: Florian
authors: F
authors: Lordick
authors: Lars
authors: L
authors: Grenacher
authors: Markus
authors: M
authors: Buechler
authors: Katja
authors: K
authors: Ott
references: Cancer. 2003 Oct 1;98(7):1521-30
references: 14508841
references: J Clin Oncol. 2007 May 20;25(15):2107-16
references: 17513817
references: Lancet Oncol. 2010 May;11(5):439-49
references: 20409751
references: Gastrointest Cancer Res. 2008 Nov;2(6):287-94
references: 19259277
references: AJR Am J Roentgenol. 2005 Nov;185(5):1152-8
references: 16247125
references: Am J Gastroenterol. 2009 Mar;104(3):566-73
references: 19223887
references: Eur Radiol. 1999;9(1):68-72
references: 9933383
references: Ann Surg. 2007 Jul;246(1):1-8
references: 17592282
references: World J Surg. 2005 Dec;29(12):1576-84
references: 16317484
references: Gastric Cancer. 2003;6(3):159-67
references: 14520529
references: Radiology. 2007 Feb;242(2):472-82
references: 17255419
references: Dig Dis. 2008;26(4):285-90
references: 19188716
references: Ann Surg. 1999 Aug;230(2):170-8
references: 10450730
references: J Comput Assist Tomogr. 1998 Mar-Apr;22(2):288-94
references: 9530396
references: Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):288-95
references: 12552348
references: J Natl Med Assoc. 1995 Jun;87(6):423-6
references: 7595964
references: Cancer. 1993 Oct 1;72(7):2089-97
references: 8374867
references: J Clin Oncol. 1989 Sep;7(9):1318-26
references: 2769330
references: Ann Surg. 1998 Oct;228(4):449-61
references: 9790335
references: J Clin Oncol. 1997 May;15(5):2015-21
references: 9164213
references: N Engl J Med. 1999 Mar 25;340(12):908-14
references: 10089184
references: N Engl J Med. 2008 Jul 31;359(5):453-62
references: 18669424
references: Br J Surg. 1992 Feb;79(2):156-60
references: 1555065
references: Radiology. 2004 Feb;230(2):465-71
references: 14752188
references: Ann Surg. 2010 Mar;251(3):428-35
references: 20179530
references: Ann Surg. 1989 Nov;210(5):596-602
references: 2818028
references: J Clin Oncol. 2004 Jun 1;22(11):2069-77
references: 15082726
references: N Engl J Med. 2006 Jul 6;355(1):11-20
references: 16822992
references: Ann Surg Oncol. 2010 Oct;17(10):2733-9
references: 20490698
references: Eur Radiol. 2000;10(12):1877-85
references: 11305564
references: Lancet Oncol. 2006 Apr;7(4):309-15
references: 16574546
references: Ann Surg. 1989 Feb;209(2):162-6
references: 2644898
references: J Nucl Med. 2007 Dec;48(12):1945-50
references: 18006614
references: Langenbecks Arch Chir Suppl Kongressbd. 1998;115:717-9
references: 9931709
references: J Comput Assist Tomogr. 2006 May-Jun;30(3):372-7
references: 16778609
references: Br J Surg. 1989 Sep;76(9):905-8
references: 2804584
references: Br J Cancer. 1999 Mar;79(9-10):1522-30
references: 10188901
references: Gastrointest Endosc. 2004 May;59(6):619-26
references: 15114303